Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of Exelixis Inc (NASDAQ: EXEL) was $41.87 for the day, down -0.71% from the previous closing price of $42.17. In other words, the price has decreased by -$0.71 from its previous closing price. On the day, 2.89 million shares were traded. EXEL stock price reached its highest trading level at $42.73 during the session, while it also had its lowest trading level at $41.52.
Ratios:
Our analysis of EXEL’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.36 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 14.40. For the most recent quarter (mrq), Quick Ratio is recorded 3.68 and its Current Ratio is at 3.75. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.08.
Leerink Partners Upgraded its Market Perform to Outperform on October 21, 2025, while the target price for the stock was maintained at $48.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 25 ’25 when JOHNSON DAVID EDWARD bought 27,532 shares for $43.12 per share. The transaction valued at 1,187,235 led to the insider holds 1,553,262 shares of the business.
Haley Patrick J. sold 34,187 shares of EXEL for $1,431,757 on Nov 20 ’25. The EVP, Commercial now owns 0 shares after completing the transaction at $41.88 per share. On Nov 21 ’25, another insider, Haley Patrick J., who serves as the EVP, Commercial of the company, sold 28,043 shares for $42.58 each. As a result, the insider received 1,194,071 and left with 374,029 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EXEL now has a Market Capitalization of 11271510016 and an Enterprise Value of 10494217216. As of this moment, Exelixis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.63, and their Forward P/E ratio for the next fiscal year is 12.96. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.39. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.91 while its Price-to-Book (P/B) ratio in mrq is 5.20. Its current Enterprise Value per Revenue stands at 4.586 whereas that against EBITDA is 12.346.
Stock Price History:
The Beta on a monthly basis for EXEL is 0.40, which has changed by 0.19057035 over the last 52 weeks, in comparison to a change of 0.12529528 over the same period for the S&P500. Over the past 52 weeks, EXEL has reached a high of $49.62, while it has fallen to a 52-week low of $31.90. The 50-Day Moving Average of the stock is 2.88%, while the 200-Day Moving Average is calculated to be 4.92%.
Shares Statistics:
EXEL traded an average of 2.73M shares per day over the past three months and 2638660 shares per day over the past ten days. A total of 268.10M shares are outstanding, with a floating share count of 259.68M. Insiders hold about 3.15% of the company’s shares, while institutions hold 95.93% stake in the company. Shares short for EXEL as of 1763078400 were 20145618 with a Short Ratio of 7.37, compared to 1760486400 on 20882902. Therefore, it implies a Short% of Shares Outstanding of 20145618 and a Short% of Float of 10.38.
Earnings Estimates
Currently, 13.0 analysts are dedicated to thoroughly evaluating and rating the performance of Exelixis Inc (EXEL) in the stock market.The consensus estimate for the next quarter is $0.67, with high estimates of $0.82 and low estimates of $0.59.
Analysts are recommending an EPS of between $3.18 and $2.16 for the fiscal current year, implying an average EPS of $2.92. EPS for the following year is $3.29, with 13.0 analysts recommending between $3.94 and $2.55.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 17 analysts. It ranges from a high estimate of $631.03M to a low estimate of $530.39M. As of. The current estimate, Exelixis Inc’s year-ago sales were $566.75MFor the next quarter, 17 analysts are estimating revenue of $624.23M. There is a high estimate of $667.6M for the next quarter, whereas the lowest estimate is $593.67M.
A total of 19 analysts have provided revenue estimates for EXEL’s current fiscal year. The highest revenue estimate was $2.35B, while the lowest revenue estimate was $2.31B, resulting in an average revenue estimate of $2.34B. In the same quarter a year ago, actual revenue was $2.17BBased on 19 analysts’ estimates, the company’s revenue will be $2.61B in the next fiscal year. The high estimate is $2.96B and the low estimate is $2.44B.
